Disrupt Fentanyl Pill Production Act
Latest Action
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Disrupt Fentanyl Pill Production Act is a House bill introduced in the 118th Congress aimed at addressing the production of fentanyl pills. The bill was referred to the House Committees on Energy and Commerce and Judiciary for consideration. The bill's text and official summary are not available, and it has been classified as failed or expired as of the latest update. The bill falls under the health policy area and appears to focus on legislative measures related to fentanyl, a synthetic opioid linked to public health concerns.
This bill sought to address fentanyl pill production through legislative action but did not advance beyond committee referral and is now considered failed or expired.
- The bill was introduced in the House during the 118th Congress and referred to relevant committees for review.
- It is categorized under the health policy area, indicating a focus on public health and drug control.
- The bill did not progress past committee referral and is currently classified as failed or expired.
['Public health agencies involved in opioid crisis management', 'Law enforcement agencies tasked with controlling illegal drug production', 'Communities affected by fentanyl-related overdoses and health issues']
['Lack of available full text and official summary limits understanding of specific provisions and implementation details.', "The bill's failure to advance may reflect challenges in legislative consensus or prioritization.", 'Potential costs and enforcement mechanisms are unknown due to missing bill text.']
The bill was introduced in the House and referred to the Committees on Energy and Commerce and Judiciary, which have jurisdiction over health and legal matters respectively. The referral indicates the bill contained provisions relevant to these areas. The bill did not advance further and is now considered failed or expired, reflecting the legislative process and committee review stages in Congress.
Hidden impact flags detected: 1
GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential increased focus on fentanyl-related health and law enforcement initiatives if similar legislation is reintroduced.', 'Possible influence on future legislative proposals addressing opioid production and distribution.']
Due to the lack of available full text and official summary, transparency and oversight are limited for this bill. Stakeholders cannot fully evaluate the scope, funding, enforcement, or specific policy mechanisms proposed. Monitoring future related bills for more detailed disclosures is recommended.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.